• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re

  2026-05-25

  Xiao et al. (2024) reveal how 25-hydroxycholesterol (25HC) accumulates in tumor-associated macrophages (TAMs), activating lysosomal AMPK and STAT6 signaling to enhance immunosuppression. Targeting the CH25H/25HC axis disrupts this program, improving anti-tumor responses and sensitizing tumors to checkpoint blockade therapies.

• Cy3 Goat Anti-Human IgG (H+L) Antibody for High-Fidelity Imm

  2026-05-24

  The Cy3 Goat Anti-Human IgG (H+L) Antibody delivers unmatched sensitivity and reproducibility across immunofluorescence, immunohistochemistry, flow cytometry, and ELISA. Learn how to maximize its performance in complex workflows and draw translational insights from recent orthopoxvirus antibody research.

• Safe DNA Gel Stain: Next-Level Nucleic Acid Detection in Pla

  2026-05-23

  Explore how Safe DNA Gel Stain transforms DNA and RNA gel staining with enhanced safety and sensitivity. This in-depth article uniquely links the stain’s molecular advantages to modern plant genomics and food safety research.

• X-press Tag Peptide: Streamlining N-terminal Leader Purifica

  2026-05-22

  X-press Tag Peptide from APExBIO elevates protein purification with a modular N-terminal leader, integrating a polyhistidine sequence and Xpress epitope for precise affinity workflows. Its high solubility and clean enterokinase cleavage site empower sensitive studies—especially those targeting protein modifications like mTORC1 neddylation.

• Oligo (dT) 25 Beads: Reliable Magnetic Bead-Based mRNA Isola

  2026-05-22

  Oligo (dT) 25 Beads are designed for efficient eukaryotic mRNA isolation, supporting workflows requiring high-purity, intact mRNA, such as RT-PCR and next-generation sequencing. These beads should not be used for non-polyadenylated RNA or prokaryotic samples, and are best suited for protocols where rapid, magnetic bead-based separation is advantageous.

• c-Myc Tag Peptide: Catalyzing Precision in Transcription Fac

  2026-05-21

  This thought-leadership article explores the mechanistic, workflow, and translational significance of the c-Myc tag Peptide for researchers dissecting transcription factor biology. Blending cutting-edge insights from autophagy-driven transcriptional control and competitive product intelligence, it offers actionable guidance for deploying this tool in advanced immunoassays and cancer biology, with a forward-looking perspective on future research frontiers.

• VX-765: Precision Caspase-1 Inhibition for Inflammation Rese

  2026-05-21

  VX-765, a potent and selective caspase-1 inhibitor, enables targeted inhibition of IL-1β and IL-18 release in cell and animal models of inflammation. Its unique selectivity profile, robust oral bioavailability, and proven efficacy in both autoimmune and infectious disease models distinguish it as an indispensable tool for dissecting pyroptosis and inflammatory signaling.

• TBXA2R-ERM Axis Drives Metastasis in Triple-Negative Breast

  2026-05-20

  This study identifies the thromboxane A2 receptor (TBXA2R) as a key upstream activator of ezrin, radixin, and moesin (ERM) proteins, which drive motility, invasion, and metastasis in triple-negative breast cancer (TNBC) cells. By dissecting the signaling axis linking GPCR activity to cytoskeletal remodeling, the research advances understanding of metastatic mechanisms and offers new targets for therapeutic intervention.

• GRA12: A Conserved Virulence Factor in Toxoplasma gondii Str

  2026-05-20

  This article reviews the discovery of GRA12 as a pan-strain virulence effector in Toxoplasma gondii, highlighting its cross-strain and cross-host relevance. The study’s pooled CRISPR-Cas9 screens and mechanistic validation illuminate new directions for understanding parasite immune evasion and host-pathogen interactions.

• BMAL1 Regulates Senescence and Apoptosis Resistance via AP-1

  2026-05-19

  Jachim et al. reveal that BMAL1, a core circadian clock transcription factor, is upregulated in senescent cells and directly modulates key features of the senescence program through AP-1 motif interaction. This mechanistic insight links circadian regulation with apoptosis resistance in aging, with implications for therapeutic targeting of senescent cells.

• Cimetidine: Unlocking Translational Potential in Cancer and

  2026-05-19

  This thought-leadership article explores the unique mechanistic and translational value of Cimetidine—an H2 receptor antagonist with partial agonist activity—in gastrointestinal cancer and blood-brain barrier research. Integrating evidence from recent high-throughput BBB modeling advances and APExBIO’s high-purity offering, the piece supplies experimental and strategic guidance for translational researchers, while distinguishing itself from conventional product coverage.

• FLAG tag Peptide (DYKDDDDK): Precision in Protein Purificati

  2026-05-18

  The FLAG tag Peptide (DYKDDDDK) enables gentle, high-specificity purification and detection of recombinant proteins, streamlining workflows in molecular bioscience. This guide translates recent reference findings and best practices into actionable protocols, troubleshooting, and comparative insights that maximize yield, reproducibility, and assay flexibility.

• Verteporfin-Induced IRE1α Activation Synergizes with AKT Inh

  2026-05-18

  This study identifies verteporfin as a molecular glue that induces IRE1α dimerization and activation, leading to downstream modulation of PTEN, AKT, and BACH1 in breast cancer. The findings reveal that combining verteporfin with AKT inhibition results in synergistic suppression of tumor growth, offering mechanistic insights for therapeutic strategies targeting the unfolded protein response.

• Lipid Scrambling Regulates Ferroptosis and Tumor Immune Reje

  2026-05-17

  Yang et al. uncover TMEM16F-mediated lipid scrambling as a key suppressor of ferroptosis by orchestrating phospholipid redistribution at the plasma membrane. Inhibiting this process sensitizes tumor cells to ferroptosis and boosts immune rejection, revealing a novel axis for cancer therapy.

• Pol II Degradation Triggers Apoptosis Independent of Transcr

  2026-05-16

  This study uncovers that targeted degradation of RNA Polymerase II (Pol II) initiates apoptosis via a mechanism that does not require global transcriptional shutdown. The findings redefine how transcriptional machinery integrity is linked to cell fate, offering new conceptual frameworks for apoptosis induction in cancer research.

16769 records 1/1118 page Next 12345 下5页 Last page